influenza
Sanofi set for €170 million expansion of vaccine facility
October 12, 2017Manufacturing and Production Sanofi, Sanofi Pasteur, biotech, drugs, influenza, pharma, pharmaceutical
Sanofi has announced that it plans to expand its vaccine manufacturing facility in Val de Reuil, France, with an injection …
‘Universal flu vaccine’ to be trialed this winter
October 3, 2017Manufacturing and Production, Medical Communications Flu virus, Vaccine, biotech, drugs, influenza, pharma, pharmaceutical
Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of …
Collaboration brings forward potential broad flu cure
October 2, 2017Research and Development, Sales and Marketing biotech, drugs, flu, influenza, pharma, pharmaceutical
A joint research effort between The Scripps Research Institute and Janssen has seen the development of a peptide that could …
Swine flu pandemic linked to increased incidence of diabetes
September 19, 2017Manufacturing and Production, Research and Development biotech, diabetes type 1, drugs, influenza, pharma, pharmaceutical, swine flu
The swine flu pandemic that swept the world in 2009 may have had unforeseen consequences in some populations, after researchers …
Asthma drugs may have alternative function as pneumonia treatment
March 1, 2017Research and Development asthma, influenza, pneumonia
Researchers from the University of Virginia School of Medicine have discovered that two drugs commonly used to treat asthma, Accolate …
Influenza vaccine market to grow to £4.3 billion by 2025
October 31, 2016Sales and Marketing influenza
GlobalData has released new findings which indicate that the seasonal influenza vaccine market is set to be worth $4.3 billion …
MHRA approves Sanofi Pasteur MSD’s four-strain influenza vaccine for UK use
July 25, 2016Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi pasteur msd, UK, Vaccine, flu, influenza
Sanofi Pasteur MSD has announced the approval of the latest addition to its family of influenza vaccines in the UK: …
CSL’s flu vaccine scores FDA approval
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing CSL, FDA, Vaccine, flu, four strain, four-strain, influenza, influenza a, influenza b, seqirus
Seqirus, a division of CSL, has announced that the US Food and Drug Administration (FDA) has approved Flucelvax Quadrivalent (influenza …
Sanofi Pasteur ‘actively exploring’ universal flu vaccine
November 10, 2015Manufacturing and Production, Research and Development SEEK, Sanofi Pasteur, influenza, universal flu vaccine
Sanofi Pasteur is developing a universal, cross-reactive antigen against seasonal and pandemic influenza, the company has revealed.The French firm presented its …
China flu vaccine gets WHO seal of approval
June 12, 2015Research and Development, Sales and Marketing Hualan Biological Bacterin, WHO, influenza
A Chinese influenza vaccine has been deemed safe and effective by The World Health Organization (WHO). The approval makes its …
Novartis back under microscope
June 23, 2014Medical Communications, Sales and Marketing Italy, Novartis, avastin, fraud, influenza, vaccines
Novartis is under the microscope yet again in Italy, with police visiting the company’s sites at Siena and Origgio in …
Doctors use GSK’s Pandemrix as seasonal flu vaccines fall short
January 10, 2011Sales and Marketing GSK, GlaxoSmithKline, Pandemrix, flu, h1n1, influenza, vaccines
Doctors may have to use last year’s stock of the H1N1 vaccine Pandemrix as the government admits there are some …
Flu ad campaign dusted off as cases rise
January 5, 2011Medical Communications NHS, UK, disease awareness, flu, influenza
The Department of Health this week relaunched its advertising campaign to remind people of the importance of good hand and …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
